# Sugammadex and Decreased Time to Extubation

> **NCT03196167** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 90 (actual)

## Conditions studied

- Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery

## Interventions

- **DRUG:** Sugammadex
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03196167
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-13
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03196167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03196167, "Sugammadex and Decreased Time to Extubation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03196167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*